Vice President Of Sales
Tnh Specialty Pharmacy Ii
• 4-year revenue growth from $30 M to $487 M with no exclusive payor contracts and very limited access to limited distribution therapies. • Created and implemented a 3-year national expansion plan across 15 states yielding each region's ROI of $4 M in year one, and $9M or more in year two. • Created and implemented the company's first goal setting system within annual, quarterly, and monthly projections and quotas. • Created and implemented recruitment and retention programs; training, hiring, and succession planning. • Created, implemented, and supervised the launch of 340b services, leading to 4 hospital contracts within a single year. • Company Lead for online provider and sales portals upgrades. Upgrades yielded ease of use for both customers and employees, greater utilization, and increased revenues.• Planned, budgeted, and coordinated national seminars. • Calculated monthly sales commission for sales team of 20+ reps.• Reduced individual sales rep 's monthly spending during revenue growth from $2500 to $1800.• Maintained an extensive knowledge of competitors, their offerings and their presence in assigned territory.• Served on Pharma Accounts Board and instrumental in acquiring LDD rights to; Cosentyx, Ibrance, Taltz, Xtandi, and previously held Genentech LDD drugs. For each new LDD launch we acquired, TNH served as top 5 SP's for Nrx/headcount.